Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES Registry.

Heart
Magda HerasDESCARTES Investigators

Abstract

To analyse intensity of treatment of high-risk patients with non-ST elevation acute coronary syndromes (NSTEACS) included in the DESCARTES (Descripción del Estado de los Sindromes Coronarios Agudos en un Registro Temporal Español) registry. Patients with NSTEACS (n = 1877) admitted to 45 randomly selected Spanish hospitals in April and May 2002 were studied. Patients with ST segment depression and troponin rise were considered high risk (n = 478) and were compared with non-high risk patients (n = 1399). 46.9% of high-risk patients versus 39.5% of non-high-risk patients underwent angiography (p = 0.005), 23.2% versus 18.8% (p = 0.038) underwent percutaneous revascularisation, and 24.9% versus 7.4% (p < 0.001) were given glycoprotein IIb/IIIa inhibitor. In-hospital and six-month mortality were 7.5% versus 1.1% and 17% versus 4.6% (p < 0.001), respectively. A treatment score (> or = 4, 2-3 and < 2) was defined according to the number of class I interventions recommended in clinical guidelines: aspirin, clopidogrel, beta blockers, angiotensin-converting enzyme inhibitors, statins and revascularisation. Independent predictors of six-month mortality were age (odds ratio (OR) 1.07, 95% confidence interval (CI) 1.04 to 1.10, p < 0.001)...Continue Reading

References

Jun 23, 2001·The New England Journal of Medicine·C P CannonUNKNOWN TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy)--Thrombolysis
Oct 5, 2001·Journal of the American College of Cardiology·B LindahlUNKNOWN FRISC II(Fast Revascularization during InStability in CAD) Investigators
Dec 31, 2002·European Heart Journal·Michel E BertrandUNKNOWN Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology
Jul 10, 2003·Journal of the American College of Cardiology·Eric D PetersonUNKNOWN National Registry of Myocardial Infarction (NRMI) 4 Investigators
Apr 24, 2004·Revista española de cardiología·Gaietà Permanyer Miralda, Ignacio Ferreira González
Oct 30, 2004·American Heart Journal·E Magnus OhmanUNKNOWN CRUSADE Investigators
Mar 23, 2005·European Heart Journal·Yonathan HasinUNKNOWN Working Group on Acute Cardiac Care of the European Society of Cardiology
Jul 2, 2005·American Heart Journal·Mardi Gomberg-MaitlandChristopher P Cannon

❮ Previous
Next ❯

Citations

Mar 31, 2012·Expert Review of Cardiovascular Therapy·Frans Van de WerfWojtek Wojakowski
Aug 18, 2016·European Heart Journal. Cardiovascular Pharmacotherapy·Héctor Bueno
Dec 7, 2011·Thrombosis Research·Matteo Nicola Dario Di MinnoGiovanni Di Minno
May 28, 2011·Revista española de cardiología·Manuel F Jiménez-NavarroEduardo de Teresa-Galván
Jan 18, 2011·Annales de cardiologie et d'angéiologie·L LorgisY Cottin
May 25, 2007·Revista española de cardiología·Joaquín J AlonsoUNKNOWN Grupo de Estudio sobre las Unidades Coronarias de Cuidados Intermedios
Nov 3, 2007·The American Journal of Geriatric Cardiology·Ilan GottliebJoão A C Lima
Feb 3, 2012·Pharmacoepidemiology and Drug Safety·Lucía Cea SorianoLuis A García Rodríguez
Apr 27, 2011·European Journal of Clinical Investigation·Alberto CorderoUNKNOWN en nombre de los investigadores del estudio PAMISCA
Apr 1, 2009·American Heart Journal·Rajeev V RaoUNKNOWN Canadian Global Registry of Acute Coronary Events (GRACE/GRACE(2)) Investigators
Dec 17, 2014·Revista clínica española·D Fernández-BergésJ R López-Mínguez
Sep 7, 2012·European Journal of Preventive Cardiology·Kamilu M Karaye, Abdulrazaq G Habib
Dec 25, 2009·Circulation. Cardiovascular Quality and Outcomes·Sharif A HalimL Kristin Newby

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.